Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(13/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(13/week)
News
United States
(421/week)
Manufacturing
(319/week)
Technology
(320/week)
Energy
(213/week)
Other Manufacturing
(264/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
CSL Limited
Oct 29, 2020
Seqirus Presents First-of-its-Kind Study on Cell-Based Quadrivalent Influenza Vaccine (QIVc) Efficacy in Children >=2 to <18 Years Old at the European Society for Paediatric Infectious Diseases (ESPID)
Jul 30, 2020
Seqirus Begins Shipping 2020/21 Influenza Vaccines to U.S. Market
Jun 12, 2020
CSL Behring to Attend and Sponsor World Federation of Hemophilia First Ever Virtual Summit
Jun 08, 2020
CSL Behring to Acquire Biotech Company Vitaeris
Jun 05, 2020
The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
Jun 02, 2020
CSL Behring and Seattle Children's Research Institute to Advance Gene Therapy Treatments for Primary Immunodeficiency Diseases
May 27, 2020
Thermo Fisher Scientific and CSL Enter Strategic Partnership to Provide Best-in-Class Pharma Services
Apr 21, 2020
CSL Behring Announces Results from Three Analyses of Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) in Primary Immunodeficiency (PI)
Mar 25, 2020
PharmaJet Announces Appointment of Pharmaceutical Executive Dr. Marie Mazur to the Board of Directors
Feb 24, 2020
Seqirus Receives FDA Approval for FLUAD® QUADRIVALENT (Influenza Vaccine, Adjuvanted) for Adults 65 Years and Older
Feb 13, 2020
University City Science Center partnership with CSL Behring accelerates the search for new biotherapies at the University of Pittsburgh and the University of Delaware
Jan 21, 2020
Forbes Magazine Ranks CSL Behring Among Best Employers for Diversity
Jan 09, 2020
Global Biotech Leader CSL to Present at 38th Annual J.P. Morgan Healthcare Conference
Dec 09, 2019
HIZENTRA® (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Nov 12, 2019
Influenza Vaccine Market to Reach $6.20 Bn, Globally, by 2026 at 5.9% CAGR: Allied Market Research
Oct 29, 2019
Global Vaccine Adjuvants Industry
Aug 30, 2019
Seqirus Presents New Clinical Data that Reinforce the Ability of MF59® Adjuvanted Seasonal and Pandemic Influenza Vaccines to Increase Immune Response
Jul 01, 2019
CSL Behring Delivers on its Promise to Advance Bleeding Disorder Treatment Research by Supporting 16 Data Presentations at ISTH 2019
Jun 20, 2019
CSL Behring to showcase clinical advances and insights in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) with Hizentra ® [human normal immunoglobulin, 20%, subcutaneous], at the 2019 Peripheral Nerve Society Annual Meeting
May 14, 2019
Haemonetics To Transfer Union, South Carolina, Manufacturing Facility To CSL Plasma Inc.
Page 1
››
Latest News
Mar 29, 2024
Universal Display Corporation to Deliver Keynote Address and Sponsor ICDT 2024
Mar 29, 2024
Cepton, Inc. Reports Fourth Quarter and Full Year 2023 Results
Mar 29, 2024
Ascent Industries Reports Fourth Quarter and Full Year 2023 Results
Mar 29, 2024
Surf Air Mobility Reports Financial Results for Fourth Quarter and Full Year Ended December 31, 2023
Mar 29, 2024
Planet Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024
Mar 29, 2024
Fastenal Releases 2024 Environmental, Social, and Governance (ESG) Report
Mar 29, 2024
Danimer Scientific Announces Fourth Quarter and Full Year 2023 Results
Mar 29, 2024
CVD Equipment Corporation Reports Fourth Quarter and Fiscal Year 2023 Financial Results
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events